Children at increased risk for celiac disease should continue to be monitored even after they have had a negative screening result once - a review of six patients
DOI:
https://doi.org/10.13112/pc.970Keywords:
Celiac Disease, Child, Risk Factors, Chromosome AberrationsAbstract
Celiac disease is more common in people with certain autoimmune diseases (type I diabetes, autoimmune thyroid disease, autoimmune liver disease), chromosomal abnormalities (Down syndrome, Turner syndrome or Williamson syndrome), immunoglobulin A deficiency or a positive family history of celiac disease. These people should be screened for celiac disease even if they have no symptoms. In this case report, we would like to present six patients who were found to have an increased risk of celiac disease and were later diagnosed with celiac disease at the Children's Hospital Zagreb despite an initially negative screening test. The patients in our case report were screened for the following risk factors: a positive family history, Down syndrome or type I diabetes. All patients initially had a negative screening test for celiac disease. The age at the start of screening varied (earliest at 16 months and latest at 3 years), as did the time it took for an initially negative screening test to become positive later in life (between 6 months and 8.5 years) and for the final diagnosis of celiac disease to be made (the earliest age at diagnosis was 22 months). The diagnosis was made in all our patients based on the guidelines of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). In summary, a single negative screening result in children with an increased risk of celiac disease does not rule out celiac disease. As celiac disease can occur at any age, children at increased risk should be regularly monitored and screened for celiac disease.
References
1. Mišak Z, Hojsak I, Despot R, i sur. Celijakija – nove smjernice, što je zaista novo? – dijagnostički postupnik Hrvatskog društva za pedijatrijsku gastroenterologiju, hepatologiju i prehranu Hrvatskog liječničkog zbora. Liječ Vjesn 2022;144;suplement 1:43–49.
2. Husby S, Koletzko S, Korponay-Szabó IR, i sur. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012; 54(1):136–60.
3. Husby S, Koletzko S, Korponay-Szabó I, i sur. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020; 70(1): 141–156.
4. Caio G, Volta U, Sapone A, i sur. Celiac disease: a comprehensive current review. BMC Med. 2019; 17(1): 142. doi: 10.1186/s12916-019-1380-z
5. Stahl M, Liu E. Epidemiology, pathogenesis, and clinical manifestations of celiac disease in children. U: UpToDate, Li BU ed. UpToDate [Internet]. Waltham, MA:UpToDate; 2024 [citirano: 25.09.2024.] Dostupno na: https://www.uptodate.com
6. Björck S, Lynch K, Brundin C, Agardh D. Repeated Screening Can Be Restricted to At-Genetic-Risk Birth Cohorts. J Pediatr Gastroenterol Nutr. 2016 Feb;62(2):271-5. doi: 10.1097/MPG.0000000000000946. PMID: 26301618.
7. Boström M, Brundin C, Björck S, Agardh D. Longitudinal screening of HLA-risk and HLA-nonrisk children for celiac disease to age 15 years: CiPiS study. J Pediatr Gastroenterol Nutr. 2024 May;78(5):1143-1148. doi: 10.1002/jpn3.12181. Epub 2024 Mar 13. PMID: 38477348.
8. Paavola S, Kurppa K, Huhtala H, Saavalainen P, Lindfors K, Kaukinen K. Coeliac disease re-screening among once seronegative at-risk relatives: A long-term follow-up study. United European Gastroenterol J. 2022 Jul;10(6):585-593. doi: 10.1002/ueg2.12255. Epub 2022 May 25. PMID: 35611878; PMCID: PMC9278577.
9. Meijer CR, Auricchio R, Putter H, i sur. Prediction Models for Celiac Disease Development in Children From High-Risk Families: Data From the PreventCD Cohort. Gastroenterology. 2022 Aug;163(2):426-436. doi: 10.1053/j.gastro.2022.04.030. Epub 2022 Apr 26. PMID: 35487291.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Melani Kain Novak, Zrinjka Mišak, Mia Šalamon Janečić

This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Paediatria Croatica, authors retain the copyright to their work and grant others the right to use, reproduce, and share their research articles in accordance with the Creative Commons Attribution License (CC BY 4.0), which allows others to distribute and build upon the work as long as they credit the author for the original creation.